Metraipolis › archive › dc_c855282e3949

Artemether/lumefantrine — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Artemether/lumefantrine
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-10T00:28:46.435Z
SHA-256 of the archived text
52cc8234daeb6359d2ca897669d2f7232c9644d4077c0626c02a88dd878d9a81
Stable URL of this page
https://metraipolis.com/documento/dc_c855282e3949

How to cite

Artemether/lumefantrine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Artemether/lumefantrine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_c855282e3949 (Metraipolis archive dc_c855282e3949, sha256 52cc8234daeb6359d2ca897669d2f7232c9644d4077c0626c02a88dd878d9a81)
BibTeX
@misc{dcc855282e3949,
  title = {Artemether/lumefantrine — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Artemether/lumefantrine},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_c855282e3949; sha256 52cc8234daeb6359d2ca897669d2f7232c9644d4077c0626c02a88dd878d9a81},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Artemether/lumefantrine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Artemether/lumefantrine, sold under the trade name Coartem among others, is a combination of the two medications artemether and lumefantrine. It is used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine. It is not typically used to prevent malaria. It is taken by mouth. Common side effects include muscle and joint pains, fever, loss of appetite, and headache. Serious side effects include prolongation of the QT interval. While not well studied, it appears to be safe for use in pregnancy. The dose does not need changing in those with mild or moderate kidney or liver problems. This combination, the first Artemisinin-based combination therapy (ACT) available worldwide, came into medical use in 1992 and was developed in China as part of the Project 523. It is on the World Health Organization's List of Essential Medicines. It is not available as a generic medication. In July 2025 that Swiss regulator Swissmedic have approved artemether-lumefantrine, the first malaria treatment specifically designed for infants and very young children. The medication is expected to gain rapid regulatory clearance in eight African nations participating in its review. Originally introduced in 1999 for broader malaria treatment, Coartem is now approved in a lower-dose formulation tailored for babies weighing under 4.5 kilograms. The new version dissolves easily—even in breast milk—and features a cherry flavor to improve ease of use for caregivers.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Artemether/lumefantrine» — https://en.wikipedia.org/wiki/Artemether/lumefantrine
Wikidata Q2981100: «combination drug» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q2981100
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Artemether/lumefantrine?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1369227849, consultata il 2026-11-10T00:25:52.018Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 9559cae6927502ba599ab88d90471e84647e1e845f4611f9a4ea1336d58520d9